4-butyrolactone has been researched along with Adenocarcinoma in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 9 (64.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alhammady, MA; El-Beih, AA; Elkhateeb, A; Gamal-Eldeen, AM; Hegazy, ME; Ohta, S; Paré, PW | 1 |
Deng, L; Feng, B; Li, K; Liang, J; Lu, Y; Ren, G; Shang, Y; Sun, Y; Wang, X; Zhou, L | 1 |
Baghy, K; Boldizsár, I; Kovalszky, I; Mervai, Z; Molnár-Perl, I; Noszál, B; Sólyomváry, A; Tóth, G | 1 |
Ayella, A; Iwamoto, T; Jiang, Y; Lim, S; Lin, D; Tomich, J; Wang, W | 1 |
Amano, Y; Fukuhara, H; Ishihara, S; Ishimura, N; Kinoshita, Y; Mishima, Y; Sanchez-Siles, AA; Takahashi, Y; Tamagawa, Y; Uno, G; Yuki, T | 1 |
Chen, CJ; Chen, YL; Harn, HJ; Lin, CJ; Lin, SZ; Su, KJ; Wei, CW; Yiang, GT; Yu, YL | 1 |
Avila, J; Cerda-García-Rojas, CM; García-Mauriño, S; Gómez-Hurtado, MA; Hernández-Hernández, JD; Joseph-Nathan, P; Manríquez-Torres, JJ; Motilva, V; Román-Marín, LU; Talero, E; Torres-Valencia, JM; Valdez-Calderón, A; Velázquez-Jiménez, R | 1 |
Blancafort, A; Cufí, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J | 1 |
Chen, XG; Huang, WB; Jia, RP; Li, WC; Qian, M; Wu, JP; Xu, LW; Xu, Z | 1 |
Adlercreutz, H; Auprich, M; Brössner, C; Fink, K; Madersbacher, S; Petritsch, K; Petritsch, P; Rehak, P | 1 |
Accioly, MT; Bozza, PT; Carrossini, N; Kaufmann, C; Maya-Monteiro, CM; Morgado-Diaz, JA; Oliveira, SS; Pacheco, P; Robbs, BK; Viola, JP | 1 |
Alali, F; Kim, GS; McLaughlin, JL; Rogers, LL; Sastrodihardjo, S; Wu, FE; Zeng, L | 1 |
Fu, LW; Huang, HB; Liang, YJ; Pan, QC | 1 |
Collan, YU; Eckerman, C; Huovinen, R; Mäkelä, SI; Needham, L; Saarinen, NM; Santti, R; Valentín-Blasini, L; Wärri, A | 1 |
14 other study(ies) available for 4-butyrolactone and Adenocarcinoma
Article | Year |
---|---|
New terpenes from the Egyptian soft coral Sarcophyton ehrenbergi.
Topics: 4-Butyrolactone; Adenocarcinoma; Animals; Anthozoa; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Egypt; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; MCF-7 Cells; Terpenes | 2014 |
Coronin3 regulates gastric cancer invasion and metastasis by interacting with Arp2.
Topics: 4-Butyrolactone; Actin-Related Protein 2; Adenocarcinoma; Aged; Cell Line, Tumor; Cell Movement; Female; Gene Knockdown Techniques; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Stomach Neoplasms | 2014 |
Endogenous enzyme-hydrolyzed fruit of Cirsium brachycephalum: optimal source of the antiproliferative lignan trachelogenin regulating the Wnt/β-catenin signaling pathway in the SW480 colon adenocarcinoma cell line.
Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Agents, Phytogenic; beta Catenin; Cell Line, Tumor; Cirsium; Colonic Neoplasms; Fruit; Glycogen Synthase Kinase 3; Humans; Lignans; Molecular Structure; Proto-Oncogene Proteins c-myc; Wnt Signaling Pathway | 2015 |
Cytostatic inhibition of cancer cell growth by lignan secoisolariciresinol diglucoside.
Topics: 4-Butyrolactone; Adenocarcinoma; Anticarcinogenic Agents; Butylene Glycols; Cell Cycle; Cell Line, Tumor; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclin A; Cytostatic Agents; Dietary Carbohydrates; Dose-Response Relationship, Drug; Glucosides; Glycosides; Humans; Lignans; Mass Spectrometry | 2010 |
Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Antigens, CD34; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Biopsy; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chi-Square Distribution; Cyclooxygenase 2; Disease Progression; Enzyme Inhibitors; Esophageal Neoplasms; Esophagoscopy; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors | 2011 |
Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells.
Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzodioxoles; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Growth Differentiation Factor 15; Humans; Immunohistochemistry; Lung Neoplasms; MAP Kinase Signaling System; Paclitaxel | 2012 |
Absolute configuration of podophyllotoxin related lignans from Bursera fagaroides using vibrational circular dichroism.
Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Benzofurans; Bursera; Cell Line, Tumor; Circular Dichroism; Colonic Neoplasms; Dioxoles; Drugs, Chinese Herbal; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Phytotherapy; Plant Extracts; Plant Exudates; Podophyllotoxin | 2011 |
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays | 2012 |
Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and Beclin-1 in the development of prostate cancer.
Topics: 4-Butyrolactone; Adenocarcinoma; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Apoptosis Regulatory Proteins; Beclin-1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chi-Square Distribution; Humans; Intramolecular Oxidoreductases; Male; Membrane Proteins; Microsomes; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prostaglandin-E Synthases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Thiophenes; Up-Regulation | 2012 |
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Aged, 80 and over; Diet; Genistein; Humans; Lignans; Male; Middle Aged; Organ Size; Phytoestrogens; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 2004 |
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells.
Topics: 4-Butyrolactone; Adenocarcinoma; Aspirin; Caco-2 Cells; Cell Growth Processes; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; HCT116 Cells; HT29 Cells; Humans; Lipid Metabolism; Organelles; Subcellular Fractions | 2008 |
Muricoreacin and murihexocin C, mono-tetrahydrofuran acetogenins, from the leaves of Annona muricata.
Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Fatty Alcohols; Furans; Humans; Lactones; Magnetic Resonance Spectroscopy; Male; Pancreatic Neoplasms; Plant Extracts; Plant Leaves; Plants, Medicinal; Prostatic Neoplasms; Spectrometry, Mass, Fast Atom Bombardment; Trees; Tumor Cells, Cultured | 1998 |
Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fatty Alcohols; Fura-2; Furans; Humans; KB Cells; Tumor Cells, Cultured | 1999 |
Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model.
Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Diet; Estrogens, Non-Steroidal; Female; Isoflavones; Lignans; Mammary Neoplasms, Experimental; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Uterus | 2001 |